AJANTPHARM

Ajanta Pharma Share PriceAjanta Pharma

₹1322.75
9 (0.69%)
As on 04 June, 2023 | 19:21 BSE: 532331 NSE: AJANTPHARM

Ajanta Pharma Performance

Day Range

  • Low
  • High
1322.75

52 Week Range

  • Low
  • High
1322.75
  • Open Price
  • Previous Close
  • Volume

Start SIP in Ajanta Pharma

Start SIP

Ajanta Pharma Share Price

  • Over 1 Month 2.29%
  • Over 3 Month 13%
  • Over 6 Month 5.58%
  • Over 1 Year 10.31%

Ajanta Pharma Key Statistics

P/E Ratio 28.3
PEG Ratio -1.6
Market Cap Cr 16,656
Price to Book Ratio 4.9
EPS 43.6
Dividend 0.5
Relative Strength Index 63.37
Money Flow Index 78.95
MACD Signal 9.46
Average True Range 30.81

Ajanta Pharma Investment Rating

  • Master Rating:
  • Ajanta Pharma has an operating revenue of Rs. 3,742.64 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 20% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 59 which is a POOR score indicating inconsistency in earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 849875837850766
Operating Expenses Qtr Cr 704715677664578
Operating Profit Qtr Cr 145159161186187
Depreciation Qtr Cr 3232323130
Interest Qtr Cr 13117
Tax Qtr Cr 3131394043
Net Profit Qtr Cr 117124167150135

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹1322.75
9 (0.69%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹1294.91
  • 50 Day
  • ₹1272.89
  • 100 Day
  • ₹1253.98
  • 200 Day
  • ₹1249.54
  • 20 Day
  • ₹1289.11
  • 50 Day
  • ₹1270.36
  • 100 Day
  • ₹1231.73
  • 200 Day
  • ₹1249.74

Ajanta Pharma Resistance and Support

PIVOT
₹1309.52
Resistance
First Resistance ₹1326.19
Second Resistance ₹1338.62
Third Resistance ₹1355.29
RSI 63.37
MFI 78.95
MACD Single Line 9.47
MACD 11.4
Support
First Resistance ₹1297.09
Second Resistance ₹1280.42
Third Resistance ₹1267.99

Ajanta Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 36,794 1,737,413 47.22
Week 74,235 5,134,065 69.16
1 Month 117,381 8,861,088 75.49
6 Month 98,075 5,693,252 58.05

Ajanta Pharma Result Highlights

Ajanta Pharma Synopsis

NSE-Medical-Generic Drugs

Ajanta Pharma Lt is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3411.27 Cr. and Equity Capital is Rs. 25.27 Cr. for the Year ended 31/03/2023. Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059.
Market Cap 16,656
Sales 3,411
Shares in Float 4.28
No of funds 197
Yield 0.53
Book Value 5.15
U/D Vol ratio 1.3
LTDebt / Equity
Alpha 0.07
Beta 0.1

Ajanta Pharma

Owner NameApr-23Mar-23Dec-22Sep-22
Promoters 66.21%66.11%66.11%70.48%
Mutual Funds 13.72%13.77%13.57%11.14%
Insurance Companies 1.36%1.3%1.28%1.01%
Foreign Portfolio Investors 10.03%10%10.07%8.23%
Financial Institutions/ Banks
Individual Investors 6.95%7.1%7.18%7.31%
Others 1.73%1.72%1.79%1.83%

Ajanta Pharma Management

Name Designation
Mr. Mannalal B Agrawal Chairman
Mr. Madhusudan B Agrawal Vice Chairman
Mr. Yogesh M Agrawal Managing Director
Mr. Rajesh M Agrawal Joint Managing Director
Dr. Anjana Grewal Independent Director
Mr. Chandrakant M Khetan Independent Director
Mr. K H Viswanathan Independent Director
Mr. Prabhakar R Dalal Independent Director

Ajanta Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ajanta Pharma Corporate Action

Date Purpose Remarks
2023-05-05 Audited Results
2023-03-10 Buy Back of shares
2023-02-01 Quarterly Results
2022-11-03 Quarterly Results & Interim Dividend
2022-07-28 Quarterly Results
Date Purpose Remarks
2022-11-14 INTERIM Rs.7.00 per share(350%)Interim Dividend
2021-11-10 INTERIM Rs.9.50 per share(475%)Interim Dividend
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 54413
Mirae Asset Large Cap Fund Regular Growth 33926
ICICI Prudential Value Discovery Fund Growth 28471
Nippon India Small Cap Fund - Growth 26294
UTI Flexi Cap Fund Regular Plan Growth 24237

Ajanta Pharma FAQs

What is Share Price of Ajanta Pharma ?

Ajanta Pharma share price is ₹1322 As on 04 June, 2023 | 19:07

What is the Market Cap of Ajanta Pharma ?

The Market Cap of Ajanta Pharma is ₹16655.5 Cr As on 04 June, 2023 | 19:07

What is the P/E ratio of Ajanta Pharma ?

The P/E ratio of Ajanta Pharma is 28.3 As on 04 June, 2023 | 19:07

What is the PB ratio of Ajanta Pharma ?

The PB ratio of Ajanta Pharma is 4.9 As on 04 June, 2023 | 19:07

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number